Regor Therapeutics Group
regor.com
Actively hiring
Drug Discovery
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
Regor combines a cutting-edge drug discovery engine with target validation and optimization for preclinical candidates in metabolism, oncology, and immunology.
News
Sermonix and Regor Announce Strategic Collaboration to Optimize Regor
Sermonix Pharmaceuticals, a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC), and Regor Therapeutics Group, a clinical-stage global biopharmaceutical company, today announced
Read more
Report
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity
Read more
Report
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders
SHANGHAI, CHINA / ACCESSWIRE / December 10, 2021 / Eli Lilly and Company (NYSE: LLY) and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for meta
Read more
Report